6 Meridian’s Tandem Diabetes Care TNDM Stock Holding History

6 Meridian’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$227K	Buy	+1,509	New	+$204K	0.02%	333

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

6 Meridian's TNDM Position: Q4 2021 in Review

6 Meridian opened a new position in Tandem Diabetes Care (TNDM) in Q4 2021: 1,509 shares worth $227K. The stake represents 0.02% of the portfolio and ranks #333 among its holdings.

388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

6 Meridian held 1,509 shares of Tandem Diabetes Care worth $227K as of Q4 2021.
Tandem Diabetes Care was a new 6 Meridian position in Q4 2021.
Tandem Diabetes Care made up 0.02% of 6 Meridian's portfolio in Q4 2021, its #333 holding.
388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.